Clinical trial
Oseltamivir Treatment for Children Less Than 24 Months of Age With Influenza
NCT00391768 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00391768 |
|---|---|
| Title | Oseltamivir Treatment for Children Less Than 24 Months of Age With Influenza |
| Official title | A Pharmacokinetic/Pharmacodynamic and Safety Evaluation of Oseltamivir (Tamiflu®) for the Treatment of Children Less Than 24 Months of Age With Confirmed Influenza Infection (CASG 114) |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Influenza |
| Intervention type | Drug |
| Interventions | oseltamivir (Tamiflu®) |
| Enrollment | 87 |
| Start date | Jan 1, 2007 |
| Primary completion | Mar 1, 2010 |
| Completion | Apr 1, 2010 |
| First posted | Oct 24, 2006 |
| Last update posted | May 1, 2013 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: